This article was originally published in The Tan Sheet
PowerBar plant closing; Medifast, investor agree on board changes; BioPharmX announces IPO; Mérieux expands southeast U.S. testing; more news in brief.
You may also be interested in...
The trade group Global Organization for EPA and DHA Omega-3 petitions FDA for an unqualified health claim related to reduced blood pressure as a surrogate marker for coronary heart disease risk.
FDA finalizes OTC dosing guidance
Changes have occurred in the management focus within the European Commission’s directorate responsible for medtech but not within the devices leadership; familiar faces remain.